Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 587 results for "fda centre for drug evaluation and re..."

Roche to initiate testing for Zika virus at U.S. Blood Centres...

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has provided approval to initiate collection and testing of blood samples for screening with the cobas ® Zika assay under an ... Barchart, 2 months ago
[x]  

1 images for "fda centre for drug evaluation and research"

OncLive, 1 month ago
JPMA

Drug and poison information centres: An emergent need for health care professionals in Pakistan

Asif Khaliq ( Institute of Business Management, Karachi, Pakistan. ) Sayeeda Amber Sayed ( Alberta Health Services, Canada. ) Abstract Objective: To determine the need of drug and poison information centres in public and private ...
 JPMA2 days ago

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA. Headquartered in Bresso, Italy, Newron Pharmaceuticals S.p.A.
 European Pharmaceutical Review1 week ago 5/18/16 - Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome  Pharmacy Choice1 week ago

Will the TTIP Harm Your Health? -Will Food, Drugs, Cosmetics, Pesticides Escape Regulation? -TTIP: Transatlantic Trade Agreement

Image: FDA microbiologist working in a biosafety laboratory Photo credit: US Food and Drug Administration / Wikimedia By Celia Wexler This article was first published by In 1960, one courageous Food and Drug Administration official ...
 Before It's News1 week ago

FDA regulation of e-cigarettes, hookahs will help curb dramatic growth in youth tobacco use, VCU expert says

The U.S. Food and Drug Administration on Thursday announced that it had finalized a rule extending its authority to regulate all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco. Most notably, as part of the new ...
 Health Canal3 weeks ago

FDA approves Nuplazid to treat hallucinations in Parkinson's disease

The US Food and Drug Administration (FDA) has approved Acadia's Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson's disease. ...
 European Pharmaceutical Review3 weeks ago 5/3/16 - FDA approves Nuplazid to treat hallucinations in Parkinson??s disease  Pharmacy Choice3 weeks ago
European Pharmaceutical Review

FDA approves Lilly's Taltz for plaque psoriasis

The US Food and Drug Administration (FDA) has approved Lilly's Taltz (ixekizumab) for the treatment of moderate-to-severe plaque psoriasis in adult patients. Taltz's active ingredient is an antibody (ixekizumab) that binds to a protein (interleukin ...
 European Pharmaceutical Review2 months ago
Pharmaceutical Technology

BioPharma Services to conduct in vivo studies of generic drug products

Pharmaceutical company BioPharma Services has received a $20m contract to conduct in vivo studies of generic drug products in human beings. The five-year contract has been awarded by the US Food and Drug Administration (FDA) division Centre for ...
 Pharmaceutical Technology6 days ago

Regulatory approval of new medical devices: cross sectional study

Hani J Marcus , clinical research fellow and specialty registrar 1 2 , Christopher J Payne , postdoctoral research fellow 1 , Archie Hughes-Hallett , clinical research fellow and , specialty registrar 1 , Adam P Marcus , foundation year trainee ...
 British Medical Journal1 week ago
EuroInvestor

Positive Results From Summit&aposs Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infection

(GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection (???CDI???), announces the presentation today of ...
 Tutorial Finder1 month ago Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infection  Benzinga.com1 month ago SUMMIT THERAPEUTICS : Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infection  4 Traders1 month ago Summit Therapeutics plc Positive Results From Summit's Phase 2 Codify Trial Presented At 26th Eccmid Conference  ADVFN UK1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less